Cancer Biomarkers Market Trends, Business Opportunity 2027-2036
The cancer biomarkers market was valued at over USD 38.74 billion in 2026 and is projected to reach USD 120.32 billion by the end of 2036, expanding at an estimated 12.0% CAGR during 2027-2036. The market is being shaped by the increasing emphasis on precision oncology, earlier cancer detection, molecular characterization of tumors, and the development of targeted therapies. Growing investment in biomarker-led clinical research is also encouraging pharmaceutical and biotechnology companies to integrate biomarker testing into drug-development programs.
